G04.0 Acute disseminated encephalitis and encephalomyelitis (ADEM)

Name of the Condition

• Acute disseminated encephalitis and encephalomyelitis (ADEM)

Summary

Acute disseminated encephalitis and encephalomyelitis (ADEM) is a rare inflammatory condition affecting the central nervous system, characterized by widespread demyelination of the brain and spinal cord. It typically presents with acute neurological symptoms and requires prompt evaluation to distinguish it from other demyelinating or infectious processes.

Causes

ADEM is thought to be an autoimmune response, often triggered by viral infections (e.g., measles, varicella-zoster) or vaccinations. The immune system mistakenly attacks myelin, the protective covering of nerve fibers, leading to inflammation and neurological dysfunction. In some cases, no clear trigger is identified.

Risk Factors

• Recent viral infection (e.g., measles, influenza) or vaccination.
• History of autoimmune disorders.
• Age (more common in children, though it can occur in adults).
• Genetic predisposition to autoimmune reactions.

Symptoms

• Rapid onset of neurological symptoms, often within days to weeks of a trigger.
• Altered mental status, confusion, or behavioral changes.
• Weakness, numbness, or paralysis in limbs.
• Visual disturbances (e.g., blurred vision, optic neuritis).
• Seizures or loss of coordination.
• Fever or headache (less common than in infectious encephalitis).

Diagnosis

Diagnosis involves clinical evaluation, neurological examination, and imaging (MRI) to identify characteristic brain and spinal cord lesions. Cerebrospinal fluid analysis may show inflammatory changes, though findings are not specific. Blood tests and infectious disease screening help rule out other causes.

Treatment Options

Treatment focuses on reducing inflammation, typically with high-dose corticosteroids (e.g., methylprednisolone). Intravenous immunoglobulin (IVIG) or plasma exchange may be used for severe cases. Supportive care, including seizure management and physical therapy, is often necessary during recovery.

Prognosis and Follow-Up

Most patients recover fully with treatment, though some experience residual neurological deficits. Follow-up includes monitoring for relapse or progression to other demyelinating diseases (e.g., multiple sclerosis). Long-term rehabilitation may be needed for persistent symptoms.

Complications

• Permanent neurological damage (e.g., weakness, cognitive impairment).
• Recurrence of symptoms (rare, but possible).
• Secondary infections due to immunosuppressive therapy.
• Emotional or psychological effects from chronic symptoms.

Lifestyle & Prevention

• Avoid known triggers (e.g., certain vaccinations if previously associated with ADEM).
• Maintain overall health to support immune function.
• Follow-up with healthcare providers for early detection of relapse.
• Engage in rehabilitation to optimize recovery.

When to Seek Professional Help

Seek immediate medical attention if experiencing sudden neurological symptoms (e.g., confusion, weakness, seizures) after a recent infection or vaccination. Early intervention improves outcomes.

Tips for Medical Coders

• Code G04.0 is specific to acute disseminated encephalitis and encephalomyelitis. Ensure documentation supports the acute, multifocal nature of the condition and distinguishes it from other encephalitides or demyelinating diseases. Include details on triggers (e.g., infection, vaccination) and clinical course when available.